Dachaigh › Scleroderma › Texas › Houston
Sgrùdaidhean clionaigeach Scleroderma ann an Houston, TX
Tha 9 sgrùdaidhean airson Scleroderma a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
A’ fastadhÌre 3
- The University of Texas Health Science Center at Houston, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A’ fastadhÌre 1
- UT MD Anderson Cancer Center, Houston
Platform Clinical Study for Conquering Scleroderma
A’ fastadhÌre 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
A’ fastadhÌre 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
A’ fastadhÌre 2
- Artiva Investigational Site Bellaire, Bellaire · 7 mìle air falbh
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
A’ fastadhÌre 2
- The University of Texas Health Science Center at Houston, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
A’ fastadhÌre 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
A’ fastadh
- The University of Texas Health Science Center at Houston, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
A’ fastadhÌre 2
- aTyr Investigative Site, Houston
Sgrùdaidhean Scleroderma ann am bailtean eile
- New York City, NY11 sgrùdadh
- Ann Arbor, MI10 sgrùdaidhean
- Chicago, IL10 sgrùdaidhean
- Boston, MA7 sgrùdaidhean
- Durham, NC7 sgrùdaidhean
- Los Angeles, CA7 sgrùdaidhean
- New Orleans, LA6 sgrùdaidhean
- Philadelphia, PA6 sgrùdaidhean
- Baltimore, MD6 sgrùdaidhean
- Dallas, TX5 sgrùdaidhean
- Pittsburgh, PA5 sgrùdaidhean
- Plantation, FL4 sgrùdaidhean
Sgrùdaidhean eile ann an Houston
- Aillse Sgamhain Neo-chealla-beag145 sgrùdaidhean
- Aillse a' bhroilleach126 sgrùdaidhean
- Aillse (gach seòrsa)121 sgrùdaidhean
- Ailse metastatach104 sgrùdaidhean
- Aillse colorectal102 sgrùdaidhean
- Cancer Ovarian89 sgrùdaidhean
- Leukemia myeloid geur85 sgrùdaidhean
- Ailseachadh nan Sgamhan78 sgrùdaidhean
- Aillse Prostata76 sgrùdaidhean
- Ailse Endometrial68 sgrùdaidhean
- Cancer Pancreatic61 sgrùdaidhean
- Melanoma59 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.